Kolexia
Baconnier Mathieu Gastro-entérologie
Baconnier Mathieu
Gastro-entérologie
Centre Hospitalier Annecy Genevois
Epagny Metz-Tessy, France
49 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Récidive tumorale locale Hémorragie Tumeurs du côlon Carcinomes Tumeurs du rectum Métastase tumorale Tumeurs de l'oesophage

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Lepage Come
Lepage Come
Hôpital François Mitterrand, Dijon, France
Faroux Roger
Faroux Roger
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
Aparicio Thomas
Aparicio Thomas
Hôpital Avicenne, Bobigny, France

Industries

Voir plus
B3TSI
4 collaboration(s)
Dernière en 2022
Zeste Research
2 collaboration(s)
Dernière en 2022
Roche
2 collaboration(s)
Dernière en 2021
Advanced Accelerator Applications
2 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
GRECCAR14: Multicentric Phase II-III Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma After a Favorable Response to Induction Chemotherapy
Essai Clinique (Institut du Cancer de Montpellier)   26 septembre 2023
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Cancers   06 avril 2023
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort.
Cancers   03 novembre 2022
LBA28 Prognostic effect of imaging and CEA follow-up in resected colorectal cancer (CRC): Final results and relapse free survival (RFS) - PRODIGE 13 a FFCD phase III trial
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.
European journal of cancer (Oxford, England : 1990)   01 juillet 2022
Aflibercept-LV5FU2 as first-line treatment of non-resectable metastatic colorectal cancers: Results of the FOLFA randomized phase II trial.
2022 ASCO Annual Meeting I   02 juin 2022
SATURNE: A Double-Blind, Randomized, Phase II/III Study Comparing the Use of Chemoembolization Combined With Sunitinib Against Chemoembolization Combined With a Placebo in Patients With Hepatocellular Carcinoma (SATURNE)
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   17 mars 2022
SURVEILLANCE: Follow-Up of Fully Resected Stage II or III Colorectal Cancer. Phase III Multicentric Prospective Randomised Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   06 décembre 2021